Portrait No. 001
Luba Perry
CEO & Co-Founder
ReConstruct Bio
Raised — $2M+ prior non-dilutive; $350K raised of $3M seed
I started ReConstruct Bio because I could no longer accept that women are expected to endure subpar reconstruction after life-altering events like breast cancer. As a regenerative medicine scientist, I repeatedly saw the disconnect. We had the scientific tools to do better, yet women were still offered synthetic implants or invasive surgeries with high complication rates and emotional cost. The turning point came when our lab successfully engineered vascularized human tissue outside the body. I realized this was not just a scientific achievement. It was an opportunity to correct a long-standing injustice in women’s healthcare. Why me, and why now? I have spent over 15 years building vascularized tissues and translating them toward the clinic, and I have listened closely to patients who feel unheard. The science is finally ready, and women are finally speaking up.
In her words
“Women should not have to compromise after surviving breast cancer. I’m building a world where they don’t.”
Chapter I
The toughest challenges you've faced as a founder.
Building ReConstruct Bio has required resilience on every level. I am leading a deep-tech biotech in a space that has been historically underfunded and underestimated. Raising capital for a science-driven company, while also being a woman, a mother of three, and an immigrant, has meant pushing through bias, skepticism, and constant pressure to shrink the vision. There were moments when investors questioned whether this problem was big enough, or whether women would accept better solutions if they took longer to develop. At the same time, the science demanded rigor, patience, and persistence. I balanced fundraising with running preclinical studies, navigating complex regulatory paths, and building a multidisciplinary team across academia and industry. Despite these challenges, we have made strong progress. We validated our technology in vivo, secured early non-dilutive and SAFE funding, built partnerships with leading academic and clinical institutions, and earned growing support from patient advocates. Every barrier strengthened my resolve. This company exists because quitting was never an option.
Chapter II
Your vision.
I am obsessed with solving one core problem. Why restoring the human body after tissue loss still requires compromise, suffering, and acceptance of “good enough,” especially for women. ReConstruct Bio exists to change what healing looks like. I envision a world where reconstruction means true restoration. Living tissue that integrates, lasts, and feels like part of you. Not foreign materials. Not repeated surgeries. Not silent disappointment. Beyond breast reconstruction, this approach has the potential to redefine how medicine treats soft-tissue loss across the body. At its heart, this is about dignity. It is about giving patients solutions that honor their bodies and their experiences. If successful, ReConstruct Bio will not just introduce a new therapy. It will help shift expectations for what women’s healthcare can and should deliver.
Chapter III
The impact you want to leave behind — for your industry, your community, and the women who come next.
I want to help change what women are taught to accept. In medicine, in entrepreneurship, and in leadership. For too long, women’s health has been underfunded, undertreated, and dismissed as “good enough.” Women founders have faced the same. My legacy is a future where women’s bodies are studied with rigor, treated with respect, and restored with dignity, and where women building bold, science driven companies are trusted, funded, and visible. If this work helps raise the standard for women’s health and lowers the barriers for the women courageous enough to lead it, that is the impact I want to leave behind.